Show source-provided references
9. MELD 3.0: The model for end-stage liver disease updated for the 21st century
10. Machine learning-based system for prediction of ascites grades in patients with liver cirrhosis using laboratory and clinical data
10.1515/cclm-2022-0454 ↗11. Lin, Y.J., Chen, R.J., Tang, J.H., Yu, C.S., Wu, J.L., Chen, L.C., and Chang, S.S. (2025). Machine learning-based prediction of decompensation in hepatitis B virus-related cirrhosis. Diagnostics, 15.
10.3390/diagnostics15212790 ↗13. Teschke, R., and Danan, G. (2023). Oxidative stress in liver pathophysiology and disease. Antioxidants, 12.
10.3390/antiox12091653 ↗14. Oxidative stress, isoprostanes and hepatic fibrosis
15. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure
10.1007/s10620-009-0990-2 ↗17. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
10.1002/hep.27210 ↗19. European Association for the Study of the Liver (2022). EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J. Hepatol., 77, 807–855.
21. Machine learning-powered 28-day mortality prediction in decompensated liver cirrhosis
10.5001/omj.2024.79 ↗22. Chen, X., Wang, Y., Xu, L., Zhang, Y., Lin, X., and Qian, J. (2025). Ascites complications risk factors of decompensated cirrhosis patients: Logistic regression and prediction model. BMC Gastroenterol., 25.
10.1186/s12876-025-04002-x ↗23. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis and spontaneous bacterial peritonitis?
24. Oxidative stress markers in patients with liver cirrhosis: Lack of association with Child–Pugh score and ascites severity
25. Using machine learning methods to predict hepatic encephalopathy in cirrhotic patients with unbalanced data
26. Shi, M., Chen, F., Hong, Z., Yao, A., Liu, Y., Chen, H., and Chen, H. (2023). Cellular pathogenesis of hepatic encephalopathy: An update. Biomolecules, 13.
10.3390/biom13020396 ↗28. Sfarti, C., Ciobica, A., Balmus, I.M., Ilie, O.D., Trifan, A., Petrea, O., Cojocariu, C., Gîrleanu, I., Sîngeap, A.M., and Stanciu, C. (2020). Systemic oxidative stress markers in cirrhotic patients with hepatic encephalopathy: Possible connections with systemic ammoniemia. Medicina, 56.
10.3390/medicina56040196 ↗29. GC–MS and GC–MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations
30. Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunt
10.1016/j.eclinm.2024.103001 ↗31. Liu, Y., Ding, K., Qiu, Y., Wang, P., Wang, R., Zeng, X., and Yin, C. (2025). Interpretable machine learning model for predicting covert hepatic encephalopathy in patients with cirrhosis: A multicenter study. Front. Med., 12.
10.3389/fmed.2025.1686005 ↗